Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation.

Markus LenzhoferMelchior HohensinnWolfgang HitzlVeit SteinerArmin MotaabbedKarolina MotlochHans Peter ColvinHerbert A ReitsamerSarah Moussa

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

The present study demonstrates a midterm IOP-lowering effect after COCO while reducing the burden for topical and systemic IOP-lowering medications. Patients without PEX and IOP < 30 mmHg have a lower risk of SSI. The procedure per se cannot be excluded as causative for the decreased postoperative BCVA. Further prospective investigations are suggested.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
patients undergoing
prognostic factors
minimally invasive
risk factors
patient reported outcomes
surgical site infection
drug induced